Seroprevalence of hepatitis E virus (HEV) antibody and the possible association with chronic liver disease: A case-control study in Albania

Epidemiology and Infection

Volumn 134, Issue 1, 2006, Pages 95-101

  Kondili, L A ^a   Chionne, P ^a   Porcaro, A ^a   Madonna, E ^a   Taffon, S ^a   Resuli, B ^b   Taliani, G ^c   Rapicetta, M ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b Qendra Spitalore Universitare 'Nene Tereza   (Albania)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS ANTIBODY;

ADULT; AGED; ALBANIA; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; CASE CONTROL STUDY; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; FEMALE; GROUPS BY AGE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OPTICAL DENSITY; QUANTITATIVE ANALYSIS; SEROPREVALENCE; STATISTICAL SIGNIFICANCE;

AGE FACTORS; AGED; ALBANIA; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES;

EID: 30844448791     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026880500470X     Document Type: Article

References (31)

1. Paul DA, Knigge MF, Ritter A, et al. Determination of hepatitis E virus seroprevalence by using recombinant fusion proteins and synthetic peptides. J Infect Dis 1994; 169: 801-806.
2. Balayan MS. Epidemiology of hepatitis E virus infection. J Viral Hepat 1997; 4: 155-165.
3. Center for Disease Control and Prevention. Hepatitis E among U.S. travelers, 1989-1992. Morb Mortal Wkly Rep 1993; 42: 1-4.
4. De Cock KM, Bradley DW, Sandford NL, et al. Epidemic non-A, non-B hepatitis in patients from Pakistan. Ann Intern Med 1987; 106: 227-230.
5. Zanetti AR, Dawson GJ. Hepatitis type E in Italy: A seroepidemiological survey. Study Group of hepatitis E. J Med Virol 1994; 42: 318-320.
6. Stroffolini T, Menchinelli M, Dambruoso V, et al. Prevalence of hepatitis E in a central Italian town at high endemicity for hepatitis C virus. Ital J Gastroenterol 1996; 28: 523-525.
7. Mast EE, Kuramoto IK, Favorov MO, et al. Prevalence of and risk factors for antibody to hepatitis E virus seroreactivity among blood donors in Northern California. J Infect Dis 1997; 176: 34-40.
8. Ramachandran J, Eapen C, Kang G, et al. Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease. J Gastroenterol Hepatol 2004; 19: 134-138.
9. Hamid SS, Atiq M, Shehzad F, et al. Hepatitis E virus superinfection in patients with chronic liver disease. Hepatology 2002; 36: 474-478.
10. Kondili LA, Tosti ME, Szklo M, et al. The relationships of chronic hepatitis and cirrhosis to alcohol intake, hepatitis B and C, and delta virus infection: A case-control study in Albania. Epidemiol Infect 1998; 121: 391-395.
11. Pugh RNH, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-654.
12. Malamitsi-Puchner A, Papacharitonos S, Sotos D, et al. Prevalence study of different hepatitis markers among pregnant Albanian refugees in Greece. Eur J Epidemiol 1996; 12: 297-301.
13. Chironna. M, Germinario C, Lopalco PL, Quarto M, Barbuti S. HBV, HCV and HDV infections in Albanian refugees in Southern Italy (Apulia region). Epidemiol Infect 2000; 125: 163-167.
14. Dalekos GN, Zervou E, Elisaf M, et al. Antibodies to hepatitis E virus among several populations in Greece: Increased prevalence in a haemodialysis unit. Transfusion 1998; 38: 589-595.
15. Meng XJ. Novel strains of hepatitis E virus identified from humans and other animal species: Is hepatitis E a zoonosis? J Hepatol 2000; 33: 842-845.
16. Meng XJ, Wiseman B, Elvinger F, et al. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol 2002; 40: 117-122.
17. Pisanti F, Coppola A, Galli C. Association between hepatitis C and hepatitis E viruses in southern Italy. Lancet 1994; 344: 746-747.
18. Barzilai A, Schulman S, Karetnyi YV, et al. Hepatitis E virus infection in haemophiliacs. J Med Virol 1995; 46: 153-156.
19. Psichogiou MA, Tassopoulos NC, Papatheodoridis GV, et al. Hepatitis E virus infection in a cohort of patients with acute non-A, non B hepatitis. J Hepatol 1995; 23: 668-673.
20. Psichogiou M, Tzala E, Boletis J, et al. Hepatitis E virus infection in individuals at high risk of transmission of non-A, non-B hepatitis and sexually transmitted diseases. Scand J Infect Dis 1996; 28: 443-445.
21. Koshy A, Grover S, Hyams KC, et al. Short-term IgM and IgG antibody responses to hepatitis E virus infection. Scand J Infect Dis 1996; 28: 439-441.
22. Arankalle VA, Tsarev SA, Chadha MS, et al. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J Infect Dis 1995; 171: 447-450.
23. Khuroo MS, Kamili S, Dar MY, Moeeklii R, Jameel S. Hepatitis E and long-term antibody status. Lancet 1993; 341: 1355.
24. Rapicetta M, Kondili LA, Pretolani S, et al. Sero-prevalence and anti-HEV persistence in the general population of the Republic of San Marino. J Med Virol 1999; 58: 49-53.
25. Ding X, Li TC, Hayashi S, et al. Present state of hepatitis E virus epidemiology in Tokyo, Japan. Hepatol Res 2003; 27: 169-173.
26. Tilg H, Wilmer A, Vogel W, et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992; 103: 264-274.
27. Menendez-Caro JL, Alvarez-Mon M, Giron JA, et al. Increased IgM B cell differentiation lymphokine production by T lymphocytes from patients with primary biliary cirrhosis. J Hepatol 1994; 20: 446-453.
28. Abrignani S. Antigen-independent activation of resting T-cells in the liver of patients with chronic hepatitis. Dev Biol Stand 1998; 92: 191-194.
29. Streetz KL, Tacke F, Leifeld L, et al. Interleukin 6/gp 130-dependent pathways are protective during chronic liver diseases. Hepatology 2003; 38: 218-229.
30. Mast EE, Alter MJ, Holland PV, Purcell RH. Evaluation of assays for antibody to hepatitis E virus by a serum panel Hepatitis E Virus Antibody Serum Panel Evaluation Group. Hepatology 1998; 27: 857-861.
31. Ghabrah TM, Tsarev S, Yarbough PO, et al. Comparison of tests for antibody to hepatitis E virus. J Med Virol 1998; 55: 134-137.